Giant cell myocarditis with central diabetes insipidus: A case report

2019
Abstract A 51-year-old male, previously diagnosed with central diabetes insipidusdue to lymphocytic hypophysitis, presented with fever and dyspnea for 1 week. On arrival, he exhibited hypotension (85/60 mmHg) and sinus tachycardia(110 bpm). His electrocardiogram revealed mild ST elevationon V2–V4. Echocardiography indicated a near-normal (50%) left ventricular ejection fraction (LVEF), although the inferior wall of the left ventricle exhibited severe hypokinesis. Fulminant myocarditisand circulatory insufficiency were suspected, and treatment with dobutamine, 3 μg/kg/min, was started. His LVEF gradually decreased to 20%. On day 17, he developed cardiogenic shockdue to ventricular tachycardia and underwent peripheral venous–arterial extracorporeal membrane oxygenationand intra-aortic balloon pumping. Although he did not exhibit polyuria, intravenous vasopressin infusion (0.5 U/h) was performed to maintain normonatremia. Endomyocardial biopsy results revealed the infiltration of scattered giant cells (GCs) and extensive lymphocytes. Despite immunosuppressive therapy (methylprednisolone and cyclosporine), his cardiac function did not recover. On day 36, he received a biventricular assist device; however, he died on day 47 due to the progression of sepsis and multiple organ failure. We speculate that a deficient expression of programmed cell death protein-1 was the cause of both GC myocarditisand lymphocytic hypophysitis.
    • Correction
    • Source
    • Cite
    • Save
    10
    References
    0
    Citations
    NaN
    KQI
    []
    Baidu
    map